As of mid-October 2026, Bayer's proposed $7.25 billion Roundup settlement is still waiting on final court approval, with no ruling issued since the September 14 hearing. The deal would resolve current and future claims that Roundup, the weedkiller made by Bayer's Monsanto unit, causes non-Hodgkin lymphoma, but class members cannot yet register or file a claim. The settlement has moved through several stages this year — a preliminary approval, a Supreme Court ruling on a related legal question, an appeals court decision, and a contested hearing — without reaching the one step that actually opens claims: final approval from the Missouri judge overseeing the case.
Official resources:
- Read the original research from Courthousenews — Use this page to review the original research.
- Read the official notice from Wikipedia — Use this primary source to verify the official announcement.
Table of Contents
- What Has Happened to the $7.25 Billion Settlement So Far
- Why a Supreme Court Ruling Didn't End the Case
- Who the Settlement Covers — and Who It Doesn't
- What a Class Member Can Actually Do Right Now
- What to Watch Next
- Frequently Asked Questions
What Has Happened to the $7.25 Billion Settlement So Far
Monsanto proposed the nationwide class settlement in February 2026 to resolve Roundup cancer claims on a going-forward basis, covering anyone exposed to the product before February 17, 2026, who has or later develops non-Hodgkin lymphoma. Payments under the deal are structured to run over 21 years rather than as a single payout, according to reporting from States Newsroom. Missouri Circuit Judge Timothy Boyer granted preliminary approval on March 5, 2026, which cleared the way for class members to raise objections ahead of a final ruling, as reported by Insurance Journal. Preliminary approval is a procedural green light, not a final decision — it allows the settlement process to continue while the court collects objections and sets a final hearing.
That final hearing took place on September 14, 2026, after being moved back from an earlier date. Judge Boyer heard objections from roughly 135 people who had opted into the objection process, but he reserved his decision rather than ruling that day. As of early October 2026, no final ruling had been issued, according to Bayer's own litigation statement on the hearing. The settlement's status is best described as pending, not finalized.
Why a Supreme Court Ruling Didn't End the Case
On June 25, 2026, the U.S. Supreme Court ruled 7-2 in favor of Monsanto in *Monsanto Co. v. Durnell*. The Court held that federal pesticide-labeling law, known as FIFRA, preempts state-law claims that Monsanto failed to warn consumers about Roundup's cancer risk, because the EPA had not required a cancer warning on the product's label.
That ruling resolved one specific legal theory — failure-to-warn claims — but it didn't end the broader litigation or the settlement process. The decision applies to claims arguing the label should have carried a warning; it doesn't address claims built on other legal theories, such as design defect, which argue the product itself was unreasonably dangerous regardless of labeling. That distinction matters because objectors to the settlement tried to use the ruling to shift the case into federal court. On August 27, 2026, the Eighth Circuit Court of Appeals rejected that attempt, leaving the case in Missouri state court where it had been sent back by U.S. District Judge Edward Autrey, according to Bayer's litigation statement. The settlement negotiation continued on its original track in state court.
Who the Settlement Covers — and Who It Doesn't
The proposed deal is meant to cover a large share of pending Roundup litigation. Bayer faces roughly 65,000 pending Roundup claims nationwide, and plaintiffs' counsel has estimated that more than 40,000 people could ultimately be covered if the settlement receives final approval, according to figures reported by Courthouse News. Not every Roundup claim falls inside that settlement, though.
Claims built on a design-defect theory — arguing the product was inherently dangerous rather than simply mislabeled — sit outside both the class deal and the Supreme Court's preemption ruling. A St. Louis jury trial that began September 29, 2026, for three plaintiffs not part of the class settlement, is proceeding on exactly that theory: the plaintiffs allege Monsanto inadequately tested Roundup, a claim the Supreme Court's June ruling never addressed, according to Insurance Journal's coverage of the Reuters report. That means two separate paths currently exist for people with Roundup cancer claims: the class settlement, covering failure-to-warn-type claims tied to exposure before February 17, 2026, and individual trials pursuing design-defect claims that remain untouched by either the settlement or the Supreme Court decision.
What a Class Member Can Actually Do Right Now
Because final approval hasn't been granted, the official settlement site cannot yet accept claim registrations or submissions. The site, weedkillerclass.com, states directly that this functionality is unavailable until the court issues final approval, according to the site's own opt-out page. The one deadline that has already passed is the exclusion, or opt-out, deadline, which was set for June 4, 2026.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Anyone who opted out by that date chose to preserve their right to sue individually rather than accept a settlement payment. Importantly, the settlement terms allow a class member to revoke a prior opt-out — reversing that choice and rejoining the class — at any point up until final approval is granted. For someone currently covered by the class definition, the practical options are limited to two: wait for final approval to open claim filing, or, if they already opted out, decide whether to revoke that opt-out before the window closes with final approval. There is no claims process to start yet, and no payment schedule that can be calculated, because the amount and timing depend on a ruling that hasn't been made.
What to Watch Next
The next concrete event to track is Judge Boyer's ruling on final approval, which remained outstanding as of early October 2026 following the September 14 hearing. Once that ruling comes, it will determine whether the $7.25 billion structure moves forward as proposed, gets modified in response to the roughly 135 objections raised, or faces further appeal.
Separately, the St. Louis trial that began September 29, 2026, is worth following on its own track, since its outcome won't affect the class settlement's approval but will test how design-defect claims fare in front of a jury after the Supreme Court narrowed the failure-to-warn theory. A verdict there could shape how many future plaintiffs choose to opt out of the settlement rather than accept a class payment.
Frequently Asked Questions
Has the Roundup settlement received final approval?
No. As of early October 2026, Judge Timothy Boyer had not issued a final ruling following the September 14, 2026 approval hearing, according to Bayer's litigation statement.
Can I file a claim in the Roundup settlement right now?
No. The official settlement site, weedkillerclass.com, states that claim registration and submission are unavailable until the court grants final approval.
Does the Supreme Court's ruling mean Roundup claims are dead?
No. The June 25, 2026 ruling in *Monsanto Co. v. Durnell* only preempts failure-to-warn claims; design-defect claims, like those in a St. Louis trial that began September 29, 2026, are unaffected.
Can I still join the settlement if I already opted out?
Yes. The settlement terms allow a class member to revoke a prior opt-out at any time before final approval is granted.
You Might Also Like
- Monsanto Roundup Lawsuit Settlement Payout Update for October 2026
- Monsanto Roundup Lawsuit Settlement Payouts Explained
- Depo Provera Lawsuit Settlement Update: What October 2026 Changed